Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall peptidoglycan cross-linking enzyme is a critical catalyst in the final stages of bacterial cell wall biosynthesis. Its main function is to form peptide cross-links between glycan strands in the peptidoglycan layer, providing structural integrity and rigidity to the bacterial cell wall. This process is essential for maintaining cell shape and protecting bacteria from osmotic lysis. Key enzymes include transpeptidases (Penicillin-Binding Proteins, PBPs) and LD-transpeptidases, which are targets for β-lactam antibiotics. Variations or mutations can confer antibiotic resistance.
Inhibition of peptidoglycan cross-linking, leading to weakened cell walls and bacterial lysis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Cell Wall Peptidoglycan Cross-Linking Enzyme (PBP).